Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Financial Results for year ending 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Drugs Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 27 May 2026 at the company's registered office. The meeting will consider and approve the audited standalone and consolidated financial results for the year and quarter ended 31 March 2026. The company has also closed its trading window for designated persons and their immediate relatives under its Insider Trading Prevention Code, which will remain closed until 48 hours after the results are declared. This is a standard regulatory intimation under SEBI Listing Regulations, 2015.
This is a routine announcement informing shareholders about an upcoming board meeting to approve annual and quarterly results. No specific financial details or concerning signals are provided in this filing. Shareholders should await the actual financial results expected after 27 May 2026.